WallStreetZenWallStreetZen

NYSE: MED
Medifast Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for MED

Based on 1 analyst offering 12 month price targets for Medifast Inc.
Min Forecast
$80.00+3.2%
Avg Forecast
$80.00+3.2%
Max Forecast
$80.00+3.2%

Should I buy or sell MED stock?

Based on 1 analyst offering ratings for Medifast Inc.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MED stock forecasts and price targets.

MED stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
DA Davidson
Top 6%
95
HoldMaintains$80.00+3.20%2023-08-08

1 of 1

Forecast return on equity

Is MED forecast to generate an efficient return?
Company
N/A
Industry
323.49%
Market
58.61%

Forecast return on assets

Is MED forecast to generate an efficient return on assets?
Company
N/A
Industry
5.98%

MED earnings growth forecast

How is MED forecast to perform vs Personal Services companies and vs the US market?
Company
9.01%
Industry
15.82%
Market
21.94%
MED's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
MED's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
MED's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

MED revenue growth forecast

How is MED forecast to perform vs Personal Services companies and vs the US market?
Company
7.77%
Industry
3.27%
Market
7.9%
MED's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MED's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MED vs Personal Service Stocks

TickerPricePrice TargetUp/downsideConsensus
MED$77.52$80.00+3.20%Hold
WW$9.99$12.83+28.52%Strong Buy
ROVR$5.98$6.83+14.26%Buy
CSV$30.13$42.50+41.06%Strong Buy
EM$0.83N/AN/A
View Top Personal Service Stocks

Medifast Stock Forecast FAQ

Is Medifast Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSE: MED) stock is to Hold MED stock.

Out of 1 analyst, 0 (0%) are recommending MED as a Strong Buy, 0 (0%) are recommending MED as a Buy, 1 (100%) are recommending MED as a Hold, 0 (0%) are recommending MED as a Sell, and 0 (0%) are recommending MED as a Strong Sell.

If you're new to stock investing, here's how to buy Medifast stock.

What is MED's forecast return on equity (ROE) for 2023-2025?

(NYSE: MED) forecast ROE is N/A, which is considered weak.

What is MED's Price Target?

According to 1 Wall Street analyst that have issued a 1 year MED price target, the average MED price target is $80.00, with the highest MED stock price forecast at $80.00 and the lowest MED stock price forecast at $80.00.

The Wall Street analyst predicted that Medifast's share price could reach $80.00 by Aug 8, 2024. The average Medifast stock price prediction forecasts a potential upside of 3.2% from the current MED share price of $77.52.

What is MED's forecast return on assets (ROA) for 2023-2025?

(NYSE: MED) forecast ROA is N/A, which is lower than the forecast US Personal Services industry average of 5.98%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.